PM060184
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PM060184, covering 2015-11-02 to 2021-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors [Phase 1]